1. Search Result

Search Result

Results for "464213-10-3" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-14791
    Ibipinabant

    SLV319; BMS-646256

    Cannabinoid Receptor Metabolic Disease
    Ibipinabant (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. Ibipinabant shows more than 1000-fold selectivity for CB1 over CB2 (Ki=7943 nM). Ibipinabant can be used for the research of obesity and diabetic.